B39.0 Acute pulmonary histoplasmosis capsulati

Name of the Condition

• Common Name(s): Acute Pulmonary Histoplasmosis
• Technical Term: Acute pulmonary histoplasmosis capsulati

Summary

Acute pulmonary histoplasmosis capsulati is a fungal infection caused by inhaling spores of the Histoplasma capsulatum fungus, primarily affecting the lungs. The condition is characterized by acute respiratory symptoms and is most common in regions with high levels of bird or bat droppings. Symptoms range from mild to severe, depending on the host's immune status and the extent of exposure.

Causes

Acute pulmonary histoplasmosis capsulati is caused by inhaling spores from the Histoplasma capsulatum fungus, which thrives in environments contaminated with bird or bat droppings, such as caves, old buildings, or soil. The spores become airborne when these areas are disturbed, leading to inhalation and subsequent infection. The acute form typically results from a recent, high-level exposure to the fungus.

Risk Factors

• Living or traveling in endemic areas (e.g., Ohio and Mississippi River valleys)
• Exposure to bird or bat droppings
• Activities like spelunking, demolition, or handling soil that may lead to spore inhalation
• Weakened immune system (e.g., HIV/AIDS, chemotherapy, organ transplant)

Symptoms

• Fever
• Cough (often dry or productive)
• Fatigue
• Chest pain
• Shortness of breath
• In severe cases, can mimic symptoms of tuberculosis or other acute lung infections

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. Chest X-rays or CT scans may reveal lung abnormalities, such as nodules or infiltrates. Fungal culture, antigen tests from blood or urine, or serological tests to identify antibodies to Histoplasma may confirm the infection. Bronchoscopy with sample collection may be used in severe or unclear cases.

Treatment Options

• Antifungal medications (e.g., itraconazole, amphotericin B) for moderate to severe cases
• Supportive care, including rest and hydration, for mild cases
• Monitoring for complications or progression to disseminated disease

Prognosis and Follow-Up

Most individuals with acute pulmonary histoplasmosis recover fully with appropriate treatment, especially if diagnosed early. Follow-up may include repeat imaging or laboratory tests to ensure resolution. Immunocompromised patients or those with severe disease may require longer treatment and closer monitoring for recurrence or dissemination.

Complications

• Disseminated histoplasmosis (spread to other organs)
• Chronic pulmonary histoplasmosis (persistent lung infection)
• Respiratory failure in severe cases
• Adrenal insufficiency (rare)

Lifestyle & Prevention

• Avoid areas with high bird or bat droppings, especially if immunocompromised
• Wear protective masks or respirators during activities that disturb soil or contaminated environments
• Practice good hygiene, including handwashing after outdoor activities
• Seek prompt medical attention if symptoms of respiratory infection develop after potential exposure

When to Seek Professional Help

• Persistent or worsening respiratory symptoms (e.g., cough, shortness of breath)
• High fever or chest pain
• Symptoms that do not improve with over-the-counter treatments
• Exposure to known endemic areas followed by respiratory symptoms

Tips for Medical Coders

When coding for acute pulmonary histoplasmosis capsulati (ICD10CM code B39.0), ensure documentation supports the acute nature of the infection and its primary pulmonary involvement. Include details such as symptom onset, exposure history, and diagnostic test results to confirm the diagnosis. Avoid coding for chronic or disseminated forms unless explicitly documented. Verify that the code aligns with the clinical presentation and any associated conditions.